---
title: "Antihypertensive Treatment Gaps in Nigeria: NDHS 2023–24 Machine Learning Analysis of Non‑Uptake"
id: "medrxiv-3-antihypertensive-pharmacotherapy-gaps-in-nigeria-a-predictive-machine-learning"
canonical_url: "https://medichelpline.com/clinical-feed/medrxiv-3-antihypertensive-pharmacotherapy-gaps-in-nigeria-a-predictive-machine-learning"
content_type: "clinical_feed_article"
specialty: "Cardiology"
source_name: "medRxiv (Clinical Preprints)"
source_url: "https://www.medrxiv.org/content/10.64898/2026.09.11.26362863v1?rss=1"
published_at: "2026-09-17T12:00:00.000Z"
evidence_level: "Verified Feed"
license: "CC-BY-NC-4.0 / Informational Use"
---
# Antihypertensive Treatment Gaps in Nigeria: NDHS 2023–24 Machine Learning Analysis of Non‑Uptake
## Provenance & Clinical Metadata
- **Canonical URL:** https://medichelpline.com/clinical-feed/medrxiv-3-antihypertensive-pharmacotherapy-gaps-in-nigeria-a-predictive-machine-learning
- **Specialty:** [Cardiology](https://medichelpline.com/clinical-feed/cardiology.md)
- **Primary Source:** medRxiv (Clinical Preprints)
- **Source URL:** [Original Journal Publication](https://www.medrxiv.org/content/10.64898/2026.09.11.26362863v1?rss=1)
- **Published At:** 2026-09-17T12:00:00.000Z
- **Evidence Rating:** Verified Feed
## Executive GIST (TL;DR)
- The study used the 2023–24 Nigeria Demographic and Health Survey (NDHS) individual recode files to examine non‑uptake of **antihypertensive** therapy among adults aged 15–49 who had been diagnosed with **hypertension** (2,975 women and 529 men). - Analyses applied a survey‑weighted cascade: sex‑specific logistic regression models, pooled interaction tests, and three machine learning classifiers (elastic net, random forest, XGBoost), all evaluated with survey weights and held‑out test AUC. - Timing of fieldwork during an acute macroeconomic shock (fuel subsidy removal and currency devaluation) was a significant predictor of non‑uptake for women (OR=1.14 per month) but not for men; a formal sex-by-time interaction was significant. - Geopolitical zone effects differed by sex, with several zones protective for women but posing increased risk for men (sex‑reversed patterns; interaction p≤0.007). - Diabetes status was protective for women (OR=0.34) and showed no significant interaction with sex in pooled testing. - Wealth correlated with lower non‑uptake in pooled samples (OR=0.59), appearing significant primarily among women. - Predictive performance of the three ML algorithms was similar for women (AUC 0.61–0.63) and lower for men (AUC ~0.56–0.59), reflecting the smaller male sample. - Authors conclude that hypertension treatment gaps vary by sex, zone, and macroeconomic context, arguing against a single national intervention; they recommend sex‑ and zone‑tailored programs, integration of hypertension screening into chronic disease and maternal health touchpoints, and assessment of pharmacy supply‑chain resilience. - Data access is via the DHS Program with registration; authors declared no competing interests and reported relevant ethical approvals and participant consent.
## Clinical Analysis & Structured Key Points
[](https://www.medrxiv.org/cdn-cgi/content?id=tnxVDuiQoe7z895B15Qu3ABN6I4_cH3yTgYP8fpS4gY-1789662564.1773555-1.2.1.1-534nw7wOMZfPkVQuxNeC2Bp2PhGrd9FskWBmwSRcOw8OZyI_ZiB_L_E4hyXCYlaR) [Skip to main content](https://www.medrxiv.org/content/10.64898/2026.09.11.26362863v1?rss=1#main-content) [![medRxiv](https://www.medrxiv.org/sites/default/files/medrxiv_inner_logo.png)](https://www.medrxiv.org/) * [Home](https://www.medrxiv.org/) * [Submit](https://www.medrxiv.org/submit-a-manuscript) * [FAQ](https://www.medrxiv.org/about/FAQ) * [Blog](https://connect.medrxiv.org/news/) * [ALERTS / RSS](https://www.medrxiv.org/content/alertsrss) * [Resources](https://connect.medrxiv.org/resources/) * [About](https://www.medrxiv.org/content/about-medrxiv) Search for this keyword [Advanced Search](https://www.medrxiv.org/search) Follow this preprint # Antihypertensive Pharmacotherapy Gaps in Nigeria: A Predictive Machine Learning Analysis of Treatment Uptake Amid Macroeconomic Shock, Using NDHS 2023-24 [ View ORCID Profile](http://orcid.org/0009-0008-8575-1722)Eloghosa Aisosa Nosa-Ihaza, Emmanuel Chidera Edeh, David Nnamdi Eze, Uyioghosa Nosayise Nosa-Ihaza doi: https://doi.org/10.64898/2026.09.11.26362863 [This article is a preprint and has not been certified by peer review [](https://www.medrxiv.org/about/FAQ#unrefereed)[what does this mean?](https://www.medrxiv.org/about/FAQ#unrefereed)]. It reports new medical research that has yet to be evaluated and so should _not_ be used to guide clinical practice. Eloghosa Aisosa Nosa-Ihaza 1 Marwadi University; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Eloghosa%2BAisosa%2BNosa-Ihaza%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Nosa-Ihaza%20EA&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AEloghosa%2BAisosa%2BNosa-Ihaza%2B) * [ORCID record for Eloghosa Aisosa Nosa-Ihaza](http://orcid.org/0009-0008-8575-1722 "Open in new tab") * For correspondence: eloghosa127@gmail.com Emmanuel Chidera Edeh 1 Marwadi University; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Emmanuel%2BChidera%2BEdeh%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Edeh%20EC&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AEmmanuel%2BChidera%2BEdeh%2B) David Nnamdi Eze 1 Marwadi University; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=David%2BNnamdi%2BEze%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Eze%20DN&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3ADavid%2BNnamdi%2BEze%2B) Uyioghosa Nosayise Nosa-Ihaza 2 University of Benin * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Uyioghosa%2BNosayise%2BNosa-Ihaza%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Nosa-Ihaza%20UN&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AUyioghosa%2BNosayise%2BNosa-Ihaza%2B) * [Abstract](https://www.medrxiv.org/content/10.64898/2026.09.11.26362863v1)[](https://www.medrxiv.org/panels_ajax_tab/biorxiv_tab_art/node:1302011/1) * [Info/History](https://www.medrxiv.org/content/10.64898/2026.09.11.26362863v1.article-info)[](https://www.medrxiv.org/panels_ajax_tab/biorxiv_tab_info/node:1302011/1) * [Metrics](https://www.medrxiv.org/content/10.64898/2026.09.11.26362863v1.article-metrics)[](https://www.medrxiv.org/panels_ajax_tab/article_tab_metrics/node:1302011/1) * [Data/Code](https://www.medrxiv.org/content/10.64898/2026.09.11.26362863v1.external-links)[](https://www.medrxiv.org/panels_ajax_tab/article_tab_data_code/node:1302011/1) * [ Preview PDF](https://www.medrxiv.org/content/10.64898/2026.09.11.26362863v1.full.pdf+html)[](https://www.medrxiv.org/panels_ajax_tab/biorxiv_tab_pdf/node:1302011/1) ![Loading](https://www.medrxiv.org/sites/all/modules/contrib/panels_ajax_tab/images/loading.gif) ## Abstract Background: Hypertension is the most important modifiable cardiovascular risk factor worldwide, and the prevalence is increasing in sub-Saharan Africa. Nigeria's newly released 2023-24 Demographic and Health Survey (NDHS) provides the first opportunity to explore national-level non-uptake of antihypertensive treatment using a machine-learning cascade framework, although survey fieldwork was conducted amid the unprecedented shock of fuel subsidy removal and currency devaluation in Nigeria. Objectives: To identify correlates of antihypertensive treatment non-uptake (Gap 2) among the diagnosed adults in Nigeria; test if the non-uptake varied based on when the survey was conducted during this macroeconomic shock; and compare four predictive algorithms. Methods: We used the 2023-24 Nigeria Demographic and Health Survey (NDHS) data (2,975 women diagnosed with hypertension and 529 men diagnosed with hypertension aged 15-49) to fit survey-weighted logistic regression models separately by sex and evaluated sex-by-predictor interactions in a single pooled model. We then compared the survey-weighted logistic regression model with the elastic net, random forest, and gradient boosting (XGBoost) models, all properly weighted, using held-out test-set AUC. Results: The timing of fieldwork interviews was a significant risk factor for women (OR=1.14 per month; 95% CI: 1.06-1.22; p Copyright The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a [CC-BY 4.0 International license](http://creativecommons.org/licenses/by/4.0/). bioRxiv and medRxiv thank the following for their generous financial support: > The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, The University of Edinburgh, University of Washington, and Vrije Universiteit Amsterdam. [Donate to openRxiv ](https://www.zeffy.com/en-US/donation-form/donate-to-make-a-difference-10981) [ Back to top](https://www.medrxiv.org/content/10.64898/2026.09.11.26362863v1?rss=1#page) [ Previous](https://www.medrxiv.org/content/10.64898/2026.09.11.26361370v1 "Phenotypic and genetic characterization of different modes of lifetime nicotine use in the All of Us Research Program")[Next ](https://www.medrxiv.org/content/10.64898/2026.09.11.26362406v1 "SERPINA12 Splice Site Variant in Tunisian Familial Psoriasis Vulgaris: Segregation to Inheritance") Posted September 17, 2026. [ Download PDF](https://www.medrxiv.org/content/10.64898/2026.09.11.26362863v1.full.pdf) Print/Save Options [Download PDF](https://www.medrxiv.org/content/medrxiv/early/2026/09/17/2026.09.11.26362863.full.pdf)Full Text & In-line FiguresXML [More Info](https://www.medrxiv.org/about/FAQ#PrintOptions "More Information on Print/Save Options") [ Author Declarations](https://www.medrxiv.org/content/10.64898/2026.09.11.26362863v1#p-5) [ Data/Code](https://www.medrxiv.org/content/early/2026/09/17/2026.09.11.26362863.external-links) [ Email](https://www.medrxiv.org/ "Email this Article") [ Share](https://www.medrxiv.org/) Antihypertensive Pharmacotherapy Gaps in Nigeria: A Predictive Machine Learning Analysis of Treatment Uptake Amid Macroeconomic Shock, Using NDHS 2023-24 Eloghosa Aisosa Nosa-Ihaza, Emmanuel Chidera Edeh, David Nnamdi Eze, Uyioghosa Nosayise Nosa-Ihaza medRxiv 2026.09.11.26362863; doi: https://doi.org/10.64898/2026.09.11.26362863 [This article is a preprint and has not been certified by peer review [](https://www.medrxiv.org/about/FAQ#unrefereed)[what does this mean?](https://www.medrxiv.org/about/FAQ#unrefereed)]. It reports new medical research that has yet to be evaluated and so should _not_ be used to guide clinical practice. Share This Article: Copy [![Twitter logo](https://www.medrxiv.org/sites/all/modules/highwire/highwire/images/twitter.png)](https://www.medrxiv.org/highwire_log/share/twitter?link=http%3A%2F%2Ftwitter.com%2Fshare%3Furl%3Dhttps%253A%2F%2Fwww.medrxiv.org%2Fcontent%2F10.64898%2F2026.09.11.26362863v1%26text%3DAntihypertensive%2520Pharmacotherapy%2520Gaps%2520in%2520Nigeria%253A%2520A%2520Predictive%2520Machine%2520Learning%2520Analysis%2520of%2520Treatment%2520Uptake%2520Amid%2520Macroeconomic%2520Shock%252C%2520Using%2520NDHS%25202023-24 "Share this on Twitter") [![Facebook logo](https://www.medrxiv.org/sites/all/modules/highwire/highwire/images/fb-blue.png)](https://www.medrxiv.org/highwire_log/share/facebook?link=http%3A%2F%2Fwww.facebook.com%2Fsharer.php%3Fu%3Dhttps%253A%2F%2Fwww.medrxiv.org%2Fcontent%2F10.64898%2F2026.09.11.26362863v1%26t%3DAntihypertensive%2520Pharmacotherapy%2520Gaps%2520in%2520Nigeria%253A%2520A%2520Predictive%2520Machine%2520Learning%2520Analysis%2520of%2520Treatment%2520Uptake%2520Amid%2520Macroeconomic%2520Shock%252C%2520Using%2520NDHS%25202023-24 "Share on Facebook") [![LinkedIn logo](https://www.medrxiv.org/sites/all/modules/highwire/highwire/images/linkedin-32px.png)](https://www.medrxiv.org/highwire_log/share/linkedin?link=http%3A%2F%2Fwww.linkedin.com%2FshareArticle%3Fmini%3Dtrue%26url%3Dhttps%253A%2F%2Fwww.medrxiv.org%2Fcontent%2F10.64898%2F2026.09.11.26362863v1%26title%3DAntihypertensive%2520Pharmacotherapy%2520Gaps%2520in%2520Nigeria%253A%2520A%2520Predictive%2520Machine%2520Learning%2520Analysis%2520of%2520Treatment%2520Uptake%2520Amid%2520Macroeconomic%2520Shock%252C%2520Using%2520NDHS%25202023-24%26summary%3D%26source%3DmedRxiv "Publish this post to LinkedIn") [![Mendeley logo](https://www.medrxiv.org/sites/all/modules/highwire/highwire/images/mendeley.png)](https://www.medrxiv.org/highwire_log/share/mendeley?link=http%3A%2F%2Fwww.mendeley.com%2Fimport%2F%3Furl%3Dhttps%253A%2F%2Fwww.medrxiv.org%2Fcontent%2F10.64898%2F2026.09.11.26362863v1%26title%3DAntihypertensive%2520Pharmacotherapy%2520Gaps%2520in%2520Nigeria%253A%2520A%2520Predictive%2520Machine%2520Learning%2520Analysis%2520of%2520Treatment%2520Uptake%2520Amid%2520Macroeconomic%2520Shock%252C%2520Using%2520NDHS%25202023-24 "Share on Mendeley") [ Citation Tools](https://www.medrxiv.org/ "Citation Tools") [ Get QR code](https://connect.medrxiv.org/qr/2026.09.11.26362863) * [Tweet Widget](http://twitter.com/share?url=https%3A//www.medrxiv.org/content/10.64898/2026.09.11.26362863v1&count=horizontal&via=&text=Antihypertensive%20Pharmacotherapy%20Gaps%20in%20Nigeria%3A%20A%20Predictive%20Machine%20Learning%20Analysis%20of%20Treatment%20Uptake%20Amid%20Macroeconomic%20Shock%2C%20Using%20NDHS%202023-24&counturl=www.medrxiv.org/content/10.64898/2026.09.11.26362863v1 "Tweet This") ## Subject Area * [Health Systems and Quality Improvement ](https://www.medrxiv.org/collection/health-systems-and-quality-improvement) Reviews and Context 0 Comment 0 TRIP Peer Reviews 0 Community Reviews 0 Automated Services 0 Blogs/Media 0 Author Videos **Subject Areas** [**All Articles**](https://www.medrxiv.org/content/early/recent) * [Addiction Medicine](https://www.medrxiv.org/collection/addiction-medicine) (617) * [Allergy and Immunology](https://www.medrxiv.org/collection/allergy-and-immunology) (903) * [Anesthesia](https://www.medrxiv.org/collection/anesthesia) (334) * [Cardiovascular Medicine](https://www.medrxiv.org/collection/cardiovascular-medicine) (4821) * [Dentistry and Oral Medicine](https://www.medrxiv.org/collection/dentistry-and-oral-medicine) (479) * [Dermatology](https://www.medrxiv.org/collection/dermatology) (416) * [Emergency Medicine](https://www.medrxiv.org/collection/emergency-medicine) (650) * [Endocrinology (including Diabetes Mellitus and Metabolic Disease)](https://www.medrxiv.org/collection/endocrinology-including-diabetes-mellitus-and-metabolic-disease) (1631) * [Epidemiology](https://www.medrxiv.org/collection/epidemiology) (15956) * [Forensic Medicine](https://www.medrxiv.org/collection/forensic-medicine) (33) * [Gastroenterology](https://www.medrxiv.org/collection/gastroenterology) (1203) * [Genetic and Genomic Medicine](https://www.medrxiv.org/collection/genetic-and-genomic-medicine) (7054) * [Geriatric Medicine](https://www.medrxiv.org/collection/geriatric-medicine) (733) * [Health Economics](https://www.medrxiv.org/collection/health-economics) (1065) * [Health Informatics](https://www.medrxiv.org/collection/health-informatics) (5053) * [Health Policy](https://www.medrxiv.org/collection/health-policy) (1435) * [Health Systems and Quality Improvement](https://www.medrxiv.org/collection/health-systems-and-quality-improvement) (1770) * [Hematology](https://www.medrxiv.org/collection/hematology) (586) * [HIV/AIDS](https://www.medrxiv.org/collection/hiv-aids) (1346) * [Infectious Diseases (except HIV/AIDS)](https://www.medrxiv.org/collection/infectious_diseases) (16298) * [Intensive Care and Critical Care Medicine](https://www.medrxiv.org/collection/intensive-care-and-critical-care-medicine) (1173) * [Medical Education](https://www.medrxiv.org/collection/medical-education) (670) * [Medical Ethics](https://www.medrxiv.org/collection/medical-ethics) (155) * [Nephrology](https://www.medrxiv.org/collection/nephrology) (725) * [Neurology](https://www.medrxiv.org/collection/neurology) (7283) * [Nursing](https://www.medrxiv.org/collection/nursing) (368) * [Nutrition](https://www.medrxiv.org/collection/nutrition) (1082) * [Obstetrics and Gynecology](https://www.medrxiv.org/collection/obstetrics-and-gynecology) (1242) * [Occupational and Environmental Health](https://www.medrxiv.org/collection/occupational-and-environmental-health) (1005) * [Oncology](https://www.medrxiv.org/collection/oncology) (3611) * [Ophthalmology](https://www.medrxiv.org/collection/ophthalmology) (1054) * [Orthopedics](https://www.medrxiv.org/collection/orthopedics) (398) * [Otolaryngology](https://www.medrxiv.org/collection/otolaryngology) (457) * [Pain Medicine](https://www.medrxiv.org/collection/pain-medicine) (471) * [Palliative Medicine](https://www.medrxiv.org/collection/palliative-medicine) (139) * [Pathology](https://www.medrxiv.org/collection/pathology) (709) * [Pediatrics](https://www.medrxiv.org/collection/pediatrics) (1801) * [Pharmacology and Therapeutics](https://www.medrxiv.org/collection/pharmacology-and-therapeutics) (737) * [Primary Care Research](https://www.medrxiv.org/collection/primary-care-research) (767) * [Psychiatry and Clinical Psychology](https://www.medrxiv.org/collection/psychiatry-and-clinical-psychology) (5906) * [Public and Global Health](https://www.medrxiv.org/collection/public-and-global-health) (9764) * [Radiology and Imaging](https://www.medrxiv.org/collection/radiology-and-imaging) (2429) * [Rehabilitation Medicine and Physical Therapy](https://www.medrxiv.org/collection/rehabilitation-medicine-and-physical-therapy) (1454) * [Respiratory Medicine](https://www.medrxiv.org/collection/respiratory-medicine) (1249) * [Rheumatology](https://www.medrxiv.org/collection/rheumatology) (642) * [Sexual and Reproductive Health](https://www.medrxiv.org/collection/sexual-and-reproductive-health) (772) * [Sports Medicine](https://www.medrxiv.org/collection/sports-medicine) (578) * [Surgery](https://www.medrxiv.org/collection/surgery) (780) * [Toxicology](https://www.medrxiv.org/collection/toxicology) (107) * [Transplantation](https://www.medrxiv.org/collection/transplantation) (305) * [Urology](https://www.medrxiv.org/collection/urology) (291) Evaluation/discussion of this paper x Comments 0TRiP 0Community 0Automated 0Blogs/Media 0Video 0 Comments medRxiv aims to provide a venue for anyone to comment on a medRxiv preprint. Comments are moderated for offensive or irrelevant content (this can take ~24 h). Please avo
## Related Clinical Research

- [Modifiable risk factors linked to vulnerable coronary plaques: OCT study finds 5 drivers](https://medichelpline.com/clinical-feed/medical-news-today-0-5-modifiable-risk-factors-may-fuel-high-risk-plaques-linked-to-heart-attacks.md)
- [Diet and Alzheimer’s risk: Why no single best diet fits everyone](https://medichelpline.com/clinical-feed/medical-news-today-0-is-there-a-best-diet-to-help-lower-alzheimer-s-risk.md)
- [Machine learning and deep learning prediction of hypertension and key risk factors in Bangladesh](https://medichelpline.com/clinical-feed/plos-one-12-machine-learning-and-deep-learning-based-prediction-of-hypertension-and.md)
- [Dyslipidemia care in Japan before and after the 2024 fee revision: nationwide claims analysis](https://medichelpline.com/clinical-feed/plos-one-19-real-world-patterns-of-dyslipidemia-care-before-and-after-a-national-fee.md)
- [Factors Linked to Adherence to Anti-Hypertensive Medication at a Primary Health Centre in Ndola, Z](https://medichelpline.com/clinical-feed/medrxiv-1-factors-associated-with-adherence-to-anti-hypertensive-medication-among.md)

## Navigation
- [← Back to Cardiology Feed](https://medichelpline.com/clinical-feed/cardiology.md)
- [← All Clinical Specialties](https://medichelpline.com/clinical-feed.md)
## Medical & Regulatory Disclaimer

> [!CAUTION]
> MedicHelpline content is structured for research, educational, and professional discovery purposes. It does not constitute individual medical advice, clinical diagnosis, or treatment recommendations.
> Always verify dosing, contraindications, and regulatory alerts against official product labeling and primary regulatory sources before clinical decision-making.